Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new…
CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2020 financial results after…
CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2020 financial results after…
CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2020 financial results after…
– Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall – – Approval…
SAN DIEGO–(BUSINESS WIRE)–Abcore, Inc., a leader in contract research and development of single domain antibodies announced a panel of functional…
Positive Clinical Results from Myopia Control Tests of Newly Developed “Kubota Glasses Technology” SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision”), a…
Diaceutics names its platform ‘DXRX – The Diagnostic Network™’ It will be launched in Q4, 2020 DXRX puts 2500+ laboratories…
New crowdsourced protocol builder leverages patient and clinician engagement to design more efficient clinical trials BOSTON–(BUSINESS WIRE)–Transparency Life Sciences (TLS)…